Perspective Therapeutics, Inc. (CATX)
(Delayed Data from AMEX)
$3.82 USD
-0.10 (-2.55%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $3.83 +0.01 (0.26%) 6:08 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CATX 3.82 -0.10(-2.55%)
Will CATX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CATX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CATX
electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates
Amneal Pharmaceuticals (AMRX) Q2 Earnings Top Estimates
CATX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Journey Medical (DERM) Moves 16.8% Higher: Will This Strength Last?
Down -16.6% in 4 Weeks, Here's Why Perspective Therapeutics (CATX) Looks Ripe for a Turnaround
Is Perspective Therapeutics, Inc. (CATX) Outperforming Other Medical Stocks This Year?
Other News for CATX
Perspective Therapeutics: Giving Us Some Valuable Perspective On Alpha Emitter Therapy
Perspective Therapeutics Announces Acceptance of VMT-?-NET Data for Presentation at the ESMO ...
Trust healthcare analyst holds analyst/industry conference call
Perspective Therapeutics management to meet with Piper Sandler
Perspective Therapeutics management to meet with Piper Sandler